Exact Sciences
EXAS
#1383
Rank
ยฃ9.97 B
Marketcap
ยฃ53.97
Share price
2.34%
Change (1 day)
-11.39%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ2.65 B

According to Exact Sciences's latest financial reports the company's total liabilities are ยฃ2.65 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ2.61 B-0.79%
2022-12-31ยฃ2.63 B8.02%
2021-12-31ยฃ2.43 B23.66%
2020-12-31ยฃ1.97 B114.7%
2019-12-31ยฃ0.91 B38.87%
2018-12-31ยฃ0.66 B1042.81%
2017-12-31ยฃ57.81 M70.9%
2016-12-31ยฃ33.83 M35.01%
2015-12-31ยฃ25.05 M63.63%
2014-12-31ยฃ15.31 M123.6%
2013-12-31ยฃ6.84 M-18.11%
2012-12-31ยฃ8.36 M-3.41%
2011-12-31ยฃ8.65 M-20.52%
2010-12-31ยฃ10.89 M-11.12%
2009-12-31ยฃ12.25 M112.15%
2008-12-31ยฃ5.77 M38.88%
2007-12-31ยฃ4.16 M-8.54%
2006-12-31ยฃ4.54 M-40.68%
2005-12-31ยฃ7.66 M-18.86%
2004-12-31ยฃ9.45 M-25.35%
2003-12-31ยฃ12.66 M72.96%
2002-12-31ยฃ7.32 M156.8%
2001-12-31ยฃ2.85 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.26 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ77.57 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.62 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ46.36 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France